Rare diseases
Investigational molecules
Locations
3 2nd Street Floor 4, 07311-4045, United States
Eikon Therapeutics Inc. focuses on advanced solid tumors through early-stage oncology programs that assess novel agents as single therapies and in combination with established anti-cancer agents. The portfolio includes interest in treatment-resistant disease settings and tumor control across a broad range of solid malignancies.
Research activity also includes MSI-H tumors, reflecting attention to molecularly defined subsets within advanced disease.
Eikon Therapeutics Inc. runs clinical trials in conditions such as Neoplasm, Non-small cell lung cancer stage IV, among others.
Clinical trials run by this sponsor – those enrolling participants first.
AustriaAustria
DenmarkDenmarkAustriaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
